Monitor future Form 4 filings by Peterson for any open-market purchases or grants that would signal insider conviction. The zero-share initial position suggests no pre-existing economic exposure to MLYS.
Price Chart
Executive Summary
Kristine Peterson filed an initial statement of beneficial ownership (Form 3) with the SEC, reporting zero shares owned in Mineralys Therapeutics. The filing is a routine administrative requirement for a new officer/director and contains no material financial information.
Key Facts
- Kristine Peterson filed a Form 3 initial beneficial ownership statement on October 20, 2026, for the period ending October 19, 2026.
- The filing reports zero shares beneficially owned by Peterson in Mineralys Therapeutics.
- A power of attorney (Ex-24) was included, authorizing certain individuals to file Section 16 reports on her behalf.
- Peterson's business address is c/o Mineralys Therapeutics, Inc., 150 N. Radnor Chester Road, Suite F200, Radnor, PA 19087.
Financial Impact
No financial impact, zero shares reported; no transactions disclosed.
Risk Factors
- No insider ownership signal from this filing, Peterson may accumulate shares later, but no current alignment with shareholders.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001508596-26-000003 |
| Document: 0001508596-26-000003-index-headers.html | 0001508596-26-000003 |
| Document: 0001508596-26-000003-index.html | 0001508596-26-000003 |
| Document: 0001508596-26-000003.txt | 0001508596-26-000003 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 today | Press Release | $20.59 | awaiting T+20 | awaiting T+20 | $21.38 (+3.84%) |
Oct 20, 2026 7d ago | 3 | $21.10 | awaiting T+20 | awaiting T+20 | $21.38 (+1.33%) |
Oct 20, 2026 7d ago | 3 | $21.10 | awaiting T+20 | awaiting T+20 | $21.38 (+1.33%) |
Oct 19, 2026 9d ago | 8-K | $21.58 | awaiting T+20 | awaiting T+20 | $21.38 (−0.93%) |
Oct 13, 2026 15d ago | 144 | $20.76 | awaiting T+20 | awaiting T+20 | $21.38 (+2.99%) |
Sep 30, 2026 28d ago | 144 | $23.72 | awaiting T+20 | awaiting T+20 | $21.38 (−9.87%) |
Sep 29, 2026 29d ago | Press Release | $25.13 $21.13 | ▼ −15.92% | ▼ −16.84% | $21.38 (−14.92%) |
Sep 24, 2026 4w ago | Insider Cluster | $25.86 $20.55 | ▲ +20.53% | ▲ +19.06% | $21.38 (+17.32%) |
Sep 22, 2026 5w ago | Insider Cluster | $26.89 $21.10 | ▼ −21.53% | ▼ −22.22% | $21.38 (−20.49%) |
Aug 12, 2026 10w ago | 3 | $26.09 $28.20 | ▲ +8.09% | ▲ +9.83% | $21.38 (−18.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers